SCHEMBL7180575

SCHEMBL7180575

COc1cc(OC)c(C(=O)P(=O)(C(=O)c2c(C)cccc2Cl)c2ccccc2)c(OC)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.42
KMT2A Q03164 3/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
ATM Q13315 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TOP1 P11387 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CHRNA7 P36544 1/20 0.38
PTGS2 P35354 3/20 0.38
MEN1 O00255 2/20 0.38
ABL1 P00519 1/20 0.38
SRC P12931 1/20 0.38
TRPM4 Q8TD43 1/20 0.38
ELANE P08246 1/20 0.37
CXCL12 P48061 1/20 0.37
TSHR P16473 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7175458 0.93 ABCG2 (0.46) ABCG2KMT2ATP53CYP3A4MAPT
SCHEMBL7175185 0.92 CHRNA7 (0.39) KMT2AMAPTTOP1POLBGAA
SCHEMBL7180285 0.92 KMT2A (0.44) ABCG2KMT2ATP53CYP3A4MAPT
SCHEMBL7184519 0.91 ABCG2 (0.40) ABCG2KMT2ATP53CYP3A4MAPT
SCHEMBL7175981 0.91 ABCG2 (0.44) ABCG2KMT2ATP53CYP3A4MAPT
SCHEMBL7182187 0.90 CA12 (0.43) KMT2ACYP3A4ATMPOLBCHRNA7
SCHEMBL7180885 0.89 ABCG2 (0.48) ABCG2KMT2AMAPTTOP1GAA
SCHEMBL7175574 0.88 CA12 (0.43) KMT2ACYP3A4ATMPOLBCHRNA7
SCHEMBL7180872 0.87 ABCG2 (0.39) ABCG2KMT2ATP53CYP3A4MAPT
SCHEMBL2768729 0.86 KMT2A (0.47) ABCG2KMT2ATP53CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1200943-C Organometallic acyl-aryl phosphine CIBA SC HOLDING AG (CH) 2005-05-11 CN disclosed
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed
CN-1308081-A Organometallic acyl-aryl phosphine CIBA SC HOLDING AG (CH) 2001-08-15 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 ABCG2 3732/4885KMT2A 1586/4885TP53 3575/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 ABCG2 4323/4885KMT2A 956/4885TP53 3524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.